{
    "Question": "AeproMED Innovation Corp.,Ltd. CES 2024 product highlight and specification",
    "Summary": "AeproMED Innovation Corp.,Ltd.\n\nAirHyper Platform\n\n -Intelligent inhalation therapy for chronic diseases\n -Used in pre-clinical animal tests (vaccines, respiratory drugs, lung cancer drugs)\n -Aerosol technology with integrated bio-signal detection\n\nCES 2024 Booth: Venetian Expo, Hall G – 62700 – Eureka Park",
    "Summary_cn": "AeproMED创新有限公司\n\nAirHyper平台\n\n- 用于慢性疾病的智能吸入治疗\n- 用于临床前动物试验（疫苗、呼吸道药物、肺癌药物）\n- 集成生物信号检测的气溶胶技术\n\nCES 2024展位：威尼斯人博览馆G馆-62700-Eureka公园"
}